Details of RareLED ID Assay_1045 |
Primary information | |
---|---|
GENE | PPT2 |
NUMBER OF ASSAY | 8 |
ASSAY IDs | 504510 493154 651990 743118 743127 504482 493110 743119 |
Assay Name | 1. Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds set 2,2. Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Gel-based Activity-Based Protein Profiling (ABPP) IC50 for off-target ABHD11,3. Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP,4. Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro,5. Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds,6. Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based cell-based gel-based Activity-Based Protein Profiling (ABPP) IC50 for anti-target ABHD11,7. Late stage assay provider results from the probe development effort to identify dual inhibitors of LYPLA1 and LYPLA2: Gel-based Activity-Based Protein Profiling (ABPP) IC50 for LYPLA1 and LYPLA2,8. Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in situ |
ACTIVITY | Substance BioActivity: 2 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 5 Active, 5 Activity <= 1 µM, 5 Tested Substance BioActivity: 2 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 3 Active, 4 Activity <= 1 µM, 5 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested |